Michael Grotzer
Overview
Explore the profile of Michael Grotzer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
2312
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Velz J, Freudenmann L, Medici G, Dubbelaar M, Mohme M, Ghasemi D, et al.
Nat Commun
. 2025 Feb;
16(1):1364.
PMID: 39904979
Medulloblastoma is the most frequent malignant primary brain tumor in children. Despite recent advances in integrated genomics, the prognosis in children with high-risk medulloblastoma remains devastating, and new tumor-specific therapeutic...
2.
Vogt A, Bartels L, Grotzer M, Bodenmann G, Leibundgut K, Rossler J, et al.
J Pediatr Psychol
. 2024 Sep;
49(11):818-826.
PMID: 39283710
Objective: The way in which parental posttraumatic stress symptoms (PTSS) unfold in the first year after a cancer diagnosis in their child is poorly understood. The aims of this study...
3.
Vogt A, Bartels L, Bertschi I, Mahler F, Grotzer M, Konrad D, et al.
Eur J Investig Health Psychol Educ
. 2024 Apr;
14(4):941-953.
PMID: 38667816
In couples dealing with health problems, we-disease appraisals can influence dyadic coping strategies to alleviate distress. This study describes the development and validation of a self-report scale to assess we-disease...
4.
Higi L, Schmitt R, Kaser K, Walti M, Grotzer M, Vonbach P
BMJ Paediatr Open
. 2023 Jan;
7(1).
PMID: 36697035
Background: Drug dosing errors are among the most frequent causes of preventable harm in paediatrics. Due to the complexity of paediatric pharmacotherapy and the working conditions in healthcare, it is...
5.
Santhana Kumar K, Brunner C, Schuster M, Kopp L, Gries A, Yan S, et al.
Cell Oncol (Dordr)
. 2022 Dec;
46(2):331-356.
PMID: 36495366
Purpose: Aberrant activation of the fibroblast growth factor receptor (FGFR) family of receptor tyrosine kinases drives oncogenic signaling through its proximal adaptor protein FRS2. Precise disruption of this disease-causing signal...
6.
Mueller T, Laternser S, Guerreiro Stucklin A, Gerber N, Mourabit S, Rizo M, et al.
Eur J Cancer
. 2022 Dec;
178:171-179.
PMID: 36455411
Background: Children diagnosed with diffuse midline gliomas (DMG) have an extremely poor overall survival: 9-12 months from diagnosis with currently no curative treatment options. Given DMG molecular heterogeneity, surgical biopsies...
7.
De Clercq E, Grotzer M, Landolt M, von Helversen B, Flury M, Rossler J, et al.
Pediatr Blood Cancer
. 2022 Jun;
69(9):e29792.
PMID: 35652529
Background: Diffuse intrinsic pontine glioma (DIPG) is a rare, but lethal pediatric brain tumor with a median survival of less than 1 year. Existing treatment may prolong life and control...
8.
Bataenjer R, Grotzer M, Seiler M
Pediatr Emerg Care
. 2022 Feb;
38(2):e724-e730.
PMID: 35100770
Objective: The objective of this study was to compare the frequency at which abuse is detected in institutions with mandatory skeletal surveys for infants with fractures to that in institutions...
9.
Jaboyedoff M, Rakic M, Bachmann S, Berger C, Diezi M, Fuchs O, et al.
Swiss Med Wkly
. 2021 Dec;
151:w30069.
PMID: 34964587
Background: Improvement of paediatric healthcare is hampered by inefficient processes for generating new evidence. Clinical research often requires extra encounters with patients, is costly, takes place in an artificial situation...
10.
Rakic M, Jaboyedoff M, Bachmann S, Berger C, Diezi M, do Canto P, et al.
BMC Proc
. 2021 Sep;
15(Suppl 13):19.
PMID: 34538238
Background And Purpose: Continuous improvement of health and healthcare system is hampered by inefficient processes of generating new evidence, particularly in the case of rare diseases and paediatrics. Currently, most...